Translational Cures
Translational Cures is a regulatory science drug development company aiming to accelerate the delivery of new cures to patients. They achieve this by innovating within the FDA-regulated phases of drug development, which typically represent a significant portion of cost and time. The company utilizes translational science, human intelligence, and advanced technologies such as AI, computer modeling, Bayesian evidence of effectiveness, and in vitro clinical trials. Their focus is on developing drugs for conditions where traditional large randomized clinical trials are not feasible, such as rare diseases and emergency care, as well as speeding up development for common diseases at a lower cost.
Translational Cures
Translational Cures is a regulatory science drug development company aiming to accelerate the delivery of new cures to patients. They achieve this by innovating within the FDA-regulated phases of drug development, which typically represent a significant portion of cost and time. The company utilizes translational science, human intelligence, and advanced technologies such as AI, computer modeling, Bayesian evidence of effectiveness, and in vitro clinical trials. Their focus is on developing drugs for conditions where traditional large randomized clinical trials are not feasible, such as rare diseases and emergency care, as well as speeding up development for common diseases at a lower cost.